Captrust Financial Advisors Treace Medical Concepts, Inc. Transaction History

Captrust Financial Advisors

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$6.03 - $12.88 $140,788 - $300,722	-23,348 Reduced 39.54%	35,697 $455,000
Q3 2023 Nov 14, 2023	BUY	$12.16 - $24.87 $51,704 - $105,747	4,252 Added 7.76%	59,045 $774,000
Q2 2023 Aug 14, 2023	BUY	$23.91 - $27.81 $1.31 Million - $1.52 Million	54,793 New	54,793 $1.4 Million
Q1 2022 May 16, 2022	SELL	$16.73 - $21.58 $284 - $366	-17 Reduced 20.99%	64 $1,000
Q4 2021 Feb 14, 2022	BUY	$15.48 - $26.52 $1,253 - $2,148	81 New	81 $2,000

142

39.7M

352K

269K

Ticker TMCI
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 55,403,300
Market Cap $524M
Description
Treace Medical Concepts, Inc., an orthopedic medical device company, engages in the design, manufacture, and marketing of medical devices for foot and ankle surgeons in the United States. It offers Lapiplasty procedure that allows podiatric surgeons to treat all three dimensions of the bunion, providing patients with a cosmetic and medical impro...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.